Europe, Middle East & Africa
Proof, not promises.
IQVIA is providing customers with higher levels of precision and speed on more than 150 CORE-powered studies around the world, from study design to site selection, enrollment and execution.
Experience IQVIA CORE-powered Clinical Development
The power to raise your expectations
The CORE integrates IQVIA's unparalleled data assets, advanced analytics, technologies, and domain expertise and applies them, together, to meet every customer need. In other words, it's how we surround your trial with a customized suite of capabilities and expertise to help you
-
Accelerate enrollment speeds by using data and analytics to identify the right sites and patients more accurately.
-
Mobilize referral networks and empower CRAs to help supplement and tailor recruitment.
-
Assess your protocol using real world data to reduce the risk of costly amendments or delays.
-
Forecast commercialization options during development to maximize asset value.
-
Detect risk with automated, real-time analytics to ensure patient safety and improve quality.
IQVIA CORE-powered Clinical Development
Translate science into new treatments
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Bring trials directly to patients to decrease costs, increase quality and improve access.
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Access central labs around the globe through Q² Solutions, a joint venture between IQVIA and Quest Diagnostics.
Flexibility designed for emerging biotech
Need innovative, therapeutically aligned solutions to advance your clinical program to the next milestone?
Discover how IQVIA Biotech can support you through this journey.
New product launches, clinical trial activity, and investments
Cancer treatment based on tumor signature instead of tumor type